about
Conformational Variations of Both Phosphodiesterase-5 and Inhibitors Provide the Structural Basis for the Physiological Effects of Vardenafil and SildenafilEndothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunctionEvaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot studycGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor.Pharmacological profiling of neuropeptides on rabbit vaginal wall and vaginal artery smooth muscle in vitroRepurposing phosphodiesterase-5 inhibitors as chemoadjuvants.Molecular mechanisms that could contribute to prolonged effectiveness of PDE5 inhibitors to improve erectile function.Rationale for the use of prostaglandins and phosphodiesterase inhibitors in the treatment of functional bladder disorders.Drug-related problems in patients with erectile dysfunctions and multiple comorbidities.Flavonoid glycosides isolated from Epimedium brevicornum and their estrogen biosynthesis-promoting effects.Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.Identification of cytosolic phosphodiesterases in the erythrocyte: a possible role for PDE5.Sildenafil Ameliorates Gentamicin-Induced Nephrotoxicity in Rats: Role of iNOS and eNOS.In sickness and in wealth: psychological and sexual costs of income comparison in marriage.Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction.Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1.The Beneficial Effects of Tadalafil on Renal Ischemia-Reperfusion Injury in Rats
P2860
Q27648887-9908AB74-8DB7-4672-A7A7-2097E137E2A4Q28252540-68E6357D-CC0D-42DC-8DE7-8CD9C2E522ACQ30490863-FC8B5E21-9096-4FC2-9CD4-DAC6E36AA2B7Q34244951-456C70ED-F2DF-436D-9E7A-2D54A79858F2Q34342259-953BD044-1663-4AE8-B6D4-60280A3E7739Q34593633-2DAC8D98-044F-4075-B140-15AF4C5E1577Q36952021-82C54550-6E5E-47BE-B6C3-08D1066DDFBDQ37140623-3993EE8D-BB9C-47C0-920B-FBC8449BB8E3Q37639128-3C9E8AA6-89CB-4247-A2FC-18D930F07E77Q37742049-8F210F13-04BA-4415-83A5-1F8094A6A37BQ41353422-C67523B8-A6F4-4EA4-88A8-04FD7B1E1EE9Q41733923-79DB05CB-F4CB-44ED-8B2D-10FE3664E837Q42018514-3827BA0B-5C43-49E5-9BFF-996A6E2709EFQ42183349-CCE4458A-7F9A-486E-B919-D69496E838FEQ42767815-D05CDA82-E24C-44FA-B8E9-8514ECA90307Q45722008-38BBCD3E-F09E-4FCA-8A3D-D51BEC552C6FQ50982493-7DBF1D65-5E50-4ABD-85A5-DA0EB1499E0CQ53122228-B3ADA1F7-ECEB-4067-A32F-F16A934C547EQ58487810-88A170F9-A3D4-4FBD-89A3-4492D44C7093
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
PDE5 inhibitors beyond erectile dysfunction.
@en
type
label
PDE5 inhibitors beyond erectile dysfunction.
@en
prefLabel
PDE5 inhibitors beyond erectile dysfunction.
@en
P2093
P2860
P356
P1476
PDE5 inhibitors beyond erectile dysfunction.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.IJIR.3901577
P577
2007-07-12T00:00:00Z